Pablo Moreno-Ruiz

Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features

Teijo Pellinen, Lassi Paavolainen, Alfonso Martín-Bernabé et al. · JNCI Journal of the National Cancer Institute · 2022 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +17

Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation

Pablo Moreno-Ruiz, Sara Corvigno, Nienke C. te Grootenhuis et al. · Lung Cancer · 2021 · 53 citations · Full text

Medicine, Oncology, Pathology +17

Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer

Ioannis Zerdes, Vaia Karafousia, Artur Mezheyeuski et al. · Cancers · 2021 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17

Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study

Ioannis Zerdes, Michele Simonetti, Alexios Matikas et al. · npj Breast Cancer · 2021 · 11 citations · Full text

Medicine, Immunology, Oncology +17